The Effect of Cimetidine on Verruca Plana Juvenilis: Clinical Trials in Six Patients
- 1 August 1993
- journal article
- Published by Wiley in The Journal of Dermatology
- Vol. 20 (8) , 497-500
- https://doi.org/10.1111/j.1346-8138.1993.tb01328.x
Abstract
Cimetidine is an H2‐receptor antagonist which is mainly used to treat gastrointestinal diseases. Recently, many authors have suggested that cimetidine has the ability to reverse acquired tolerance to dinitrochlorobenzene (DNCB).We have used cimetidine in six patients with verruca plana who showed no therapeutic response to DNCB. Four of them responded and showed complete disappearance of the verruca plana. The mean duration of oral cimetidine administration (1.2 g/day) was 4 weeks until the disappearance. Therefore, we suggest that oral cimetidine can be used as an effective and safe adjunctive modality for the treatment of verruca plana.Keywords
This publication has 19 references indexed in Scilit:
- The mast cell in health and diseaseJournal of the American Academy of Dermatology, 1990
- Cimetidine prevents recurrent erythema multiforme major resulting from herpes simplex virus infectionJournal of the American Academy of Dermatology, 1989
- Contact immunotherapy of resistant wartsJournal of the American Academy of Dermatology, 1988
- Cimetidine and recurrent genital herpesJournal of the American Academy of Dermatology, 1985
- Cimetidine for Herpes ZosterNew England Journal of Medicine, 1984
- Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF)Cellular Immunology, 1980
- H2-RECEPTOR ANTAGONISTS AND DELAYED HYPERSENSITIVITYThe Lancet, 1978
- EFFECT OF HISTAMINE H2-RECEPTOR ANTAGONISTS ON DELAYED HYPERSENSITIVITYThe Lancet, 1978
- ACQUIRED TOLERANCE TO DINITROCHLOROBENZENE REVERSED BY CIMETIDINEThe Lancet, 1977
- REGULATION OF ANTIBODY RESPONSE BY CELLS EXPRESSING HISTAMINE RECEPTORSThe Journal of Experimental Medicine, 1972